跳至主要内容
临床试验/NCT07541300
NCT07541300进行中(未招募)不适用

The Effects of Palm Olein and Palm Kernel Oil Diets on Gut Hormones and Appetite in Healthy Adults

Malaysia Palm Oil Board1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2026年1月12日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
36
试验地点
1
主要终点
Glucose-dependent Insulinotropic Polypeptide (GIP)

研究概览

简要总结

The goal of this clinical trial is to investigate the postprandial effect of palm olein- and palm kernel oil- diets compared to PUFA-rich diet (sunflower oil in this study) on gut hormones response and appetite in healthy adults. The main questions it aims to answer are:

• Do palm olein- and palm kernel oil-diets postulate to improve satiety and lower appetite compared to PUFA rich diet (sunflower oil) in healthy adults? Researchers will compare diets prepared with palm olain or palm kernel oil to a diet prepared with sunflower oil to see the effects of these three diets on gut hormones and satiety score.

Participants will:

  • Attend a health screening session for subjects selection according to inclusion and exclusion criteria.
  • Visit the study center three times with 2 weeks apart.
  • Provide blood samples and fill up questionnaires at different time point within 4 hours.
  • Receive a ad libitum meal after 4 hours intervention.

详细描述

Please refer to the protocol uploaded.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
Single (Participant)

入排标准

年龄范围
20 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age 20 to 45 years.
  • BMI 20 to 27.5 kg/m
  • Blood pressure with 90 to 130 mmHg for systolic and 60 to 80 mmHg for diastolic measurements.
  • Fasting blood glucose of 3.9 to 5.5 mmol/L.
  • Fasting total cholesterol < 6.0 mmol/L.
  • Fasting triglycerides < 2.3 mmol/L.
  • Not using any form of nicotine and alcohol.

排除标准

  • Diagnosed any form of heart disease, hypertension, diabetes mellitus, and metabolic syndrome with or without medication.
  • Consuming any long term prescribed medications or supplements, including hormonal contraceptive pills.
  • Having moderate anaemia with haemoglobin <110 g/l for men and <100 g/l for women.
  • Having blood clotting problem
  • Having difficulty in cannulation (small, thin or hard-to-find veins)
  • Women who are pregnant or lactating.

研究组 & 干预措施

T

Experimental

SFO-PO-PKO

干预措施: Sunflower Oil (Other)

P

Experimental

PO-PKO-SFO

干预措施: Sunflower Oil (Other)

Q

Experimental

PO-SFO-PKO

干预措施: Sunflower Oil (Other)

R

Experimental

PKO-PO-SFO

干预措施: Sunflower Oil (Other)

S

Experimental

PKO-SFO-PO

干预措施: Sunflower Oil (Other)

U

Experimental

SFO-PKO-PO

干预措施: Sunflower Oil (Other)

P

Experimental

PO-PKO-SFO

干预措施: Palm olein (Other)

P

Experimental

PO-PKO-SFO

干预措施: Palm kernel oil (Other)

Q

Experimental

PO-SFO-PKO

干预措施: Palm olein (Other)

Q

Experimental

PO-SFO-PKO

干预措施: Palm kernel oil (Other)

R

Experimental

PKO-PO-SFO

干预措施: Palm olein (Other)

R

Experimental

PKO-PO-SFO

干预措施: Palm kernel oil (Other)

S

Experimental

PKO-SFO-PO

干预措施: Palm olein (Other)

S

Experimental

PKO-SFO-PO

干预措施: Palm kernel oil (Other)

T

Experimental

SFO-PO-PKO

干预措施: Palm olein (Other)

T

Experimental

SFO-PO-PKO

干预措施: Palm kernel oil (Other)

U

Experimental

SFO-PKO-PO

干预措施: Palm olein (Other)

U

Experimental

SFO-PKO-PO

干预措施: Palm kernel oil (Other)

结局指标

主要结局

Glucose-dependent Insulinotropic Polypeptide (GIP)

时间窗: postprandial from baseline (0 min) to 4 hours

GIP analysed using ELISA kits using plasma sample.

次要结局

  • Glucagon-like Peptide 1 (GLP-1)(Postprandial from baseline (0 min) to 4 hours)
  • Peptide YY (PYY)(Postprandial from baseline (0 min) to 4 hours)
  • Ghrelin(Postprandial from baseline (0 min) to 4 hours)
  • HOMA IR(Postprandial from baseline (0 min) up to 2 hours.)
  • Cholecytokinin, CCK(Postprandial from baseline (0 min) to 4 hours.)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验